Results 131 to 140 of about 125,690 (294)

Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio‐Oncology

European Journal of Heart Failure, EarlyView.
Specific characteristics of HFpEF universal definition in cancer patients. Abstract Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized in cancer patients and survivors, yet it remains underdiagnosed and its epidemiology largely unknown.
Kalliopi Keramida, Teresa Lopez‐Fernandez, Markus S. Anker, Mark C. Petrie, Pietro Ameri, Lisa J. Anderson, Jutta Bergler‐Klein, Anita Deswal, Dimitrios Farmakis, Borja Ibañez, Carolyn S.P. Lam, Ninian N. Lang, Alexander R. Lyon, Mariana Mirabel, Brenda Moura, Walter J. Paulus, Amina Rakisheva, Gianluigi Savarese, Michele Senni, Carlo Gabriele Tocchetti, Marco Metra, Gerasimos Filippatos   +21 more
wiley   +1 more source

Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014) [PDF]

, 2017
Rafał Hładij, Renata Rajtar-Salwa, Paweł Petkow Dimitrow   +2 more
openalex   +1 more source

Left ventricular transthyretin amyloid load and apical sparing in patients with newly confirmed transthyretin amyloid cardiomyopathy

European Journal of Heart Failure, EarlyView.
In a large cohort of patients with newly diagnosed transthyretin amyloid cardiomyopathy (ATTR‐CM), echocardiographic apical sparing was associated with increased left ventricular amyloid load and atrial remodelling. Quantitative biopsy analysis revealed that Perugini scores often failed to accurately reflect myocardial amyloid burden.
Thomas Krammer, Maria J. Baier, Vanessa Lutz, Anna‐Christina Hübner, Tilman Zschiedrich, David Lukas, Christian Le Phu, Matthias Wolf, Claire Maassen, Michael Wester, Stefan Neef, Christian Schach, Can‐Martin Sag, Katja Evert, Michael Paulus, Christine Meindl, Maria Tafelmeier, Kurt Debl, Lars S. Maier, Stefan Wagner, Christoph Röcken, Julian Mustroph   +21 more
wiley   +1 more source

Natural products targeting regulated cell deaths for adriamycin-induced cardiotoxicity

Cell Death Discovery
Adriamycin (ADR), as an anti-cancer drug in routine clinical application, is utilized to treat various cancers such as ovarian cancer, hematological malignant tumor, and endometrial carcinoma.
Zheng Wang, Yanli Zhu, Yu Yao, Wenyu Zhang, Bo Wang, Jing Wang, Yang Yang, Liwen Liu   +7 more
doaj   +1 more source

Hypertrophic cardiomyopathy: Ischemia progressing to ventricular fibrillation [PDF]

, 2018
Ellis Rochelson, Lynn Nappo, Robert H. Pass   +2 more
openalex   +1 more source

Exercise in Hypertrophic Cardiomyopathy: Recent Conceptual Changes and Recommendations for Pre-Exercise Tests [PDF]

, 2023
Jiwon Seo, Eui‐Young Choi, Se‐Joong Rim   +2 more
openalex   +1 more source

Diagnostic Value of Cardiovascular Magnetic Resonance‐Derived Left Atrioventricular Coupling Index for Predicting Adverse Left Ventricular Remodeling Following ST‐Segment Elevation Myocardial Infarction

iRADIOLOGY, EarlyView.
(1) The association between left atrioventricular coupling index and adverse left ventricular remodeling in patients with ST‐segment elevation myocardial infarction remains unknown. (2) CMR‐derived Left atrioventricular coupling index in patients with acute STEMI was an independent predictor of adverse left ventricular remodeling.
Jupan Hou, Kairui Bo, Lina Dou, Jianxiu Lian, Zhonghua Sun, Hui Wang, Lei Xu   +6 more
wiley   +1 more source

Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy. [PDF]

, 1984
B Perrot, Nicolas Danchin, A. Terrier De La Chaise   +2 more
openalex   +1 more source

4D Flow MRI Velocity and Turbulence Mapping in Mild Valvular Heart Disease

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Valvular heart disease (VHD) commonly leads to the development of turbulent blood flow. Turbulent kinetic energy (TKE), measured with 4D flow MRI, may be a complement to current metrics for early identification of VHD. Purpose To investigate TKE as a marker of VHD in relation to flow velocity and cardiovascular geometry.
Tamara Bianchessi, Chiara Trenti, Carl‐Johan Carlhäll, Tino Ebbers, Jan Engvall, Farkas Vanky, Federica Viola, Petter Dyverfeldt   +7 more
wiley   +1 more source

Clinical benefits of a specialised clinic for hypertrophic cardiomyopathy [PDF]

, 2014
A. Beale, Ivan Macciocca, Alexander Olaussen, Silvana Marasco, Justin A. Mariani, A. Ellims   +5 more
openalex   +1 more source